0001209191-16-136460.txt : 20160810 0001209191-16-136460.hdr.sgml : 20160810 20160810192838 ACCESSION NUMBER: 0001209191-16-136460 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160808 FILED AS OF DATE: 20160810 DATE AS OF CHANGE: 20160810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AxoGen, Inc. CENTRAL INDEX KEY: 0000805928 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411301878 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13859 PROGRESS BLVD. STREET 2: SUITE 100 CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: (386) 462-6817 MAIL ADDRESS: STREET 1: 13859 PROGRESS BLVD. STREET 2: SUITE 100 CITY: ALACHUA STATE: FL ZIP: 32615 FORMER COMPANY: FORMER CONFORMED NAME: LECTEC CORP /MN/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mandato Joseph M CENTRAL INDEX KEY: 0001375003 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36046 FILM NUMBER: 161822657 MAIL ADDRESS: STREET 1: DE NOVO VENTURES STREET 2: 1515 EL CAMINO REAL, #150 CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-08 0 0000805928 AxoGen, Inc. AXGN 0001375003 Mandato Joseph M 14612 BIG BASIN WAY SARATOGA CA 95070 1 0 0 0 Common Stock 2016-08-08 4 S 0 107450 8.63 D 1268941 I By De Novo Ventures II, L.P. Common Stock 2016-08-09 4 S 0 42168 8.30 D 1226773 I By De Novo Ventures II, L.P. Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $8.50 and $8.67 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price. The Form 4 filed with the SEC on June 3, 2015 over reported the amount of securities beneficially owned following the reported transaction by one share, which has been corrected in this filing. The shares are owned by De Novo Ventures II, L.P. ("DNV II"). De Novo Management II, LLC is the sole general partner of DNV II. The reporting person is a managing member of De Novo Management II, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $8.27 and $8.34 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price. /s/ Joseph M. Mandato 2016-08-10